Correction to: Safety and effectiveness of vedolizumab in paediatric patients with inflammatory bowel disease: an observational multicenter Spanish study

Autor:	Marta Velasco Rodríguez-Belvís, Ricardo Torres-Peral, Gemma Pujol-Muncunill, Alejandro Rodriguez-Martinez, Ester Donat-Aliaga, Marta Carrillo-Palau, Iñaki Irastorza-Terradillos, Ruth Garcia-Romero, Montserrat Montraveta, Carlos José Ruiz-Hernández, Sonia Fernández-Fernández, Ignacio Ros-Arnal, Saioa Vicente-Santamaría, Carolina Gutiérrez-Junquera, Oscar Segarra-Cantón, Víctor Manuel Navas-López, Javier Martín de Carpi, José Miguel Martínez de Zabarte Fernández, Enrique Medina-Benitez, Laura Escartin-Madurga, María Navalon-Rubio, José Ramón Alberto-Alonso
Jazyk:	angličtina
Rok vydání:	2021
Předmět:	medicine.medical_specialty business.industry Pediatrics Perinatology and Child Health medicine Observational study medicine.disease Intensive care medicine business Inflammatory bowel disease Vedolizumab medicine.drug Paediatric patients
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23da260ac1afe5588e6a90b47b984cce https://hdl.handle.net/10668/17825 Zobrazit plný text záznamu